Caldwell Sutter Capital, Inc. Novavax Inc Transaction History
Caldwell Sutter Capital, Inc.
- $215 Billion
- Q3 2024
A detailed history of Caldwell Sutter Capital, Inc. transactions in Novavax Inc stock. As of the latest transaction made, Caldwell Sutter Capital, Inc. holds 25 shares of NVAX stock, worth $229. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25
Previous 25
-0.0%
Holding current value
$229
Previous $317,000
0.32%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NVAX
# of Institutions
286Shares Held
84.7MCall Options Held
5.38MPut Options Held
8.62M-
Vanguard Group Inc Valley Forge, PA14.1MShares$129 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$109 Million0.0% of portfolio
-
Shah Capital Management9.82MShares$90.1 Million40.63% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY6.32MShares$58 Million0.08% of portfolio
-
State Street Corp Boston, MA6.07MShares$55.7 Million0.0% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $718M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...